Marilena De Mariano

Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility

Mario Capasso, Sharon J. Diskin, Francesca Totaro et al. · Carcinogenesis · 2012 · 113 citations · Full text

Cumulative Effect, Genetics, Genetic Epidemiology +26

Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression

Vito Alessandro Lasorsa, Daniela Formicola, Piero Pignataro et al. · Oncotarget · 2016 · 86 citations · Full text

Engineering, Pathology, Key Pathways +19

Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment

Irina Lambertz, Candy Kumps, Shana Claeys et al. · Clinical Cancer Research · 2015 · 80 citations · Full text

Inhibition of N-linked glycosylation impairs ALK phosphorylation and disrupts pro-survival signaling in neuroblastoma cell lines

Federica Grosso, Marilena De Mariano, Lorena Passoni et al. · BMC Cancer · 2011 · 52 citations · Full text

Identification of GALNT14 as a novel neuroblastoma predisposition gene

Marilena De Mariano, Roberta Gallesio, Marco Chierici et al. · Oncotarget · 2015 · 43 citations · Full text

Galnt14 Mutation, Somatic Variant, Pediatric Cancer +12